Literature DB >> 18212532

P53 promoter selection: choosing between life and death.

Sanjeev Das1, Sarah A Boswell, Stuart A Aaronson, Sam W Lee.   

Abstract

A crucial unresolved issue about the genotoxic stress response is how the activation of the p53 tumor suppressor can lead either to cell cycle arrest and DNA repair or to apoptosis. p53 is one of the most important tumor suppressor proteins in the cell to prevent to heritable transfer of damaged DNA. In response to different stress conditions p53 rapidly accumulates and functions as a sequence specific DNA-binding transcription factor to regulate a large number of target genes. Activation of p53 has two major outcomes: cell cycle arrest or apoptosis. In this review we attempt to enumerate the different modifications and co-factors that influence p53 promoter selection and demonstrate how p53 chooses life or death for the cell.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18212532     DOI: 10.4161/cc.7.2.5236

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  30 in total

1.  Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD.

Authors:  Amrita Cheema; Chad D Knights; Mahadev Rao; Jason Catania; Ricardo Perez; Brigitte Simons; Sivanesan Dakshanamurthy; Vamsi K Kolukula; Maddalena Tilli; Priscilla A Furth; Christopher Albanese; Maria Laura Avantaggiati
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

2.  Differential effects on p53-mediated cell cycle arrest vs. apoptosis by p90.

Authors:  Chao Dai; Yi Tang; Sung Yun Jung; Jun Qin; Stuart A Aaronson; Wei Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

3.  Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2.

Authors:  Sridharan Rajagopalan; Antonina Andreeva; Trevor J Rutherford; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

4.  Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation.

Authors:  Yongxing Wang; Young-Ah Suh; Maren Y Fuller; James G Jackson; Shunbin Xiong; Tamara Terzian; Alfonso Quintás-Cardama; James A Bankson; Adel K El-Naggar; Guillermina Lozano
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

5.  miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.

Authors:  Seong-Yeon Park; Jung Hyun Lee; Minju Ha; Jin-Wu Nam; V Narry Kim
Journal:  Nat Struct Mol Biol       Date:  2008-12-14       Impact factor: 15.369

6.  Harmonic oscillations in homeostatic controllers: Dynamics of the p53 regulatory system.

Authors:  Ingunn W Jolma; Xiao Yu Ni; Ludger Rensing; Peter Ruoff
Journal:  Biophys J       Date:  2010-03-03       Impact factor: 4.033

Review 7.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

8.  p53: a molecular marker for the detection of cancer.

Authors:  Mark T Boyd; Nikolina Vlatkovic
Journal:  Expert Opin Med Diagn       Date:  2008-09

9.  Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.

Authors:  Hanqiao Feng; Lisa M Miller Jenkins; Stewart R Durell; Ryo Hayashi; Sharlyn J Mazur; Scott Cherry; Joseph E Tropea; Maria Miller; Alexander Wlodawer; Ettore Appella; Yawen Bai
Journal:  Structure       Date:  2009-02-13       Impact factor: 5.006

Review 10.  Targeting prostate cancer based on signal transduction and cell cycle pathways.

Authors:  John T Lee; Brian D Lehmann; David M Terrian; William H Chappell; Franca Stivala; Massimo Libra; Alberto M Martelli; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2008-06-16       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.